Sofinnova Investments focuses on backing late preclinical and clinical-stage therapeutic companies to drive medical innovation and navigate regulatory milestones.
About Sofinnova Investments
Sofinnova Investments is a longstanding biotech-focused venture firm formerly known as Sofinnova Ventures, investing predominantly in therapeutics across discovery, clinical-stage, and commercial-stage assets. The firm operates with a sector specialist mandate and a strong record of taking companies to acquisition or public exit, with a portfolio that has included multiple FDA-approved drugs and major M&A outcomes. Check sizes are large by venture standards, typically ranging from low single-digit millions in initial commitments through follow-ons that can total fifteen to thirty million dollars or more across the life of an investment, depending on the round and reserve strategy. The fit is a therapeutics company with credible science, a clear development path, and a leadership team capable of executing through multiple clinical milestones. AI-native drug discovery platforms can engage if the platform has produced specific assets or partnerships that demonstrate clinical relevance, but pure software-only theses without a therapeutic asset will not match. Digital health, devices, and provider-side enterprise software are out of scope. Founders should not approach this firm with a tech-style pitch; the lens is biopharma development, capital efficiency, and clinical risk management. The best entry path is a warm introduction from a current or former portfolio CEO, a biotech banker, an academic advisor with Sofinnova relationships, or a scientific founder in the firm’s network. Direct outreach via LinkedIn is acceptable but should be paired with a substantive scientific package, not a deck-only summary. Expect rigorous, multi-month scientific diligence and partner-level engagement throughout.
Founder reviews
Healthcare AI tools backed by Sofinnova Investments
Tools made by companies in Sofinnova Investments's portfolio that we cover in the directory.
Portfolio companies in our directory
Other portfolio companies
Companies in Sofinnova Investments's portfolio not currently in our directory.
- City Therapeutics · 2026
- Coultreon Biopharma · 2026
- ARTBIO · 2023
- Vera Therapeutics
- Avenzo Therapeutics · 2026
- Marea Therapeutics
- Quanta Therapeutics
- Star Therapeutics
- Aiolos Bio
- RayzeBio
- Atsena Therapeutics · 2020
Team
Pitch / review this investor
Have you raised from Sofinnova Investments? Founders only — share your honest experience (anonymous OK, moderated before publishing).